NEWS 

Real-time and near-time news

 

 

 

ANALYSIS

Stock analysis as news feed

 

 

VIDEO

Range of services

 

 

Newsticker

Companies
Economic News
Markets

Nektar Therapeutics Q4 Earnings Summary

|   Companies

 

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):

Earnings: $7.26 million in Q4 vs. -$42.08 million in the same period last year.

EPS: $0.03 in Q4 vs. -$0.22 in the same period last year.

Analysts projected -$0.19 per share

Revenue: $29.175 million in Q4 vs. $23.885 million in the same period last year.

Copyright(c) 2025 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

Nektar Therapeutics Q4 Earnings Summary

|   Companies

 

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):

Earnings: $7.26 million in Q4 vs. -$42.08 million in the same period last year.

EPS: $0.03 in Q4 vs. -$0.22 in the same period last year.

Analysts projected -$0.19 per share

Revenue: $29.175 million in Q4 vs. $23.885 million in the same period last year.

Copyright(c) 2025 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

Nektar Therapeutics Q4 Earnings Summary

|   Companies

 

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):

Earnings: $7.26 million in Q4 vs. -$42.08 million in the same period last year.

EPS: $0.03 in Q4 vs. -$0.22 in the same period last year.

Analysts projected -$0.19 per share

Revenue: $29.175 million in Q4 vs. $23.885 million in the same period last year.

Copyright(c) 2025 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

nach oben